Medtronic Statistics
Total Valuation
Medtronic has a market cap or net worth of $116.70 billion. The enterprise value is $140.08 billion.
Important Dates
The last earnings date was Tuesday, August 19, 2025, before market open.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | Sep 26, 2025 |
Share Statistics
Medtronic has 1.28 billion shares outstanding. The number of shares has decreased by -2.52% in one year.
| Current Share Class | 1.28B |
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | -2.52% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 86.59% |
| Float | 1.28B |
Valuation Ratios
The trailing PE ratio is 25.16 and the forward PE ratio is 15.90. Medtronic's PEG ratio is 2.75.
| PE Ratio | 25.16 |
| Forward PE | 15.90 |
| PS Ratio | 3.50 |
| Forward PS | 3.31 |
| PB Ratio | 2.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.52 |
| P/OCF Ratio | 16.71 |
| PEG Ratio | 2.75 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 14.96, with an EV/FCF ratio of 26.42.
| EV / Earnings | 30.06 |
| EV / Sales | 4.10 |
| EV / EBITDA | 14.96 |
| EV / EBIT | 21.32 |
| EV / FCF | 26.42 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.61 |
| Debt / EBITDA | 3.07 |
| Debt / FCF | 5.59 |
| Interest Coverage | 8.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.34% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $360,000 |
| Profits Per Employee | $49,053 |
| Employee Count | 95,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Medtronic has paid $971.00 million in taxes.
| Income Tax | 971.00M |
| Effective Tax Rate | 17.15% |
Stock Price Statistics
The stock price has increased by +7.07% in the last 52 weeks. The beta is 0.82, so Medtronic's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +7.07% |
| 50-Day Moving Average | 89.65 |
| 200-Day Moving Average | 87.28 |
| Relative Strength Index (RSI) | 51.20 |
| Average Volume (20 Days) | 7,477,438 |
Short Selling Information
The latest short interest is 11.60 million, so 0.91% of the outstanding shares have been sold short.
| Short Interest | 11.60M |
| Short Previous Month | 12.06M |
| Short % of Shares Out | 0.91% |
| Short % of Float | 0.91% |
| Short Ratio (days to cover) | 1.67 |
Income Statement
In the last 12 months, Medtronic had revenue of $34.20 billion and earned $4.66 billion in profits. Earnings per share was $3.62.
| Revenue | 34.20B |
| Gross Profit | 22.36B |
| Operating Income | 6.57B |
| Pretax Income | 4.81B |
| Net Income | 4.66B |
| EBITDA | 9.37B |
| EBIT | 6.57B |
| Earnings Per Share (EPS) | $3.62 |
Full Income StatementBalance Sheet
The company has $8.97 billion in cash and $29.63 billion in debt, giving a net cash position of -$20.64 billion or -$16.11 per share.
| Cash & Cash Equivalents | 8.97B |
| Total Debt | 29.63B |
| Net Cash | -20.64B |
| Net Cash Per Share | -$16.11 |
| Equity (Book Value) | 48.26B |
| Book Value Per Share | 37.46 |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.15 billion and capital expenditures -$1.84 billion, giving a free cash flow of $5.30 billion.
| Operating Cash Flow | 7.15B |
| Capital Expenditures | -1.84B |
| Free Cash Flow | 5.30B |
| FCF Per Share | $4.14 |
Full Cash Flow StatementMargins
Gross margin is 65.37%, with operating and profit margins of 19.21% and 13.63%.
| Gross Margin | 65.37% |
| Operating Margin | 19.21% |
| Pretax Margin | 16.55% |
| Profit Margin | 13.63% |
| EBITDA Margin | 27.39% |
| EBIT Margin | 19.21% |
| FCF Margin | 15.51% |
Dividends & Yields
This stock pays an annual dividend of $2.84, which amounts to a dividend yield of 3.12%.
| Dividend Per Share | $2.84 |
| Dividend Yield | 3.12% |
| Dividend Growth (YoY) | 1.44% |
| Years of Dividend Growth | 49 |
| Payout Ratio | 77.88% |
| Buyback Yield | 2.52% |
| Shareholder Yield | 5.57% |
| Earnings Yield | 3.90% |
| FCF Yield | 4.44% |
Dividend DetailsAnalyst Forecast
The average price target for Medtronic is $98.80, which is 8.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $98.80 |
| Price Target Difference | 8.48% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.32% |
| EPS Growth Forecast (5Y) | 15.60% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on September 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
